<?xml version="1.0" encoding="UTF-8" standalone="no"?>

<MINiML
   xmlns="http://www.ncbi.nlm.nih.gov/geo/info/MINiML"
   xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
   xsi:schemaLocation="http://www.ncbi.nlm.nih.gov/geo/info/MINiML http://www.ncbi.nlm.nih.gov/geo/info/MINiML.xsd"
   version="0.5.0" >

  <Contributor iid="contrib1">
    <Person><First>Chrystala</First><Last>Constantinidou</Last></Person>
    <Email>C.Constantinidou@bham.ac.uk</Email>
    <Phone>+44 (0)121  414 5564</Phone>
    <Laboratory>UBEC</Laboratory>
    <Department>School of Biosciences</Department>
    <Organization>University of Birmingham</Organization>
    <Address>
      <City>Birmingham</City>
      <Postal-Code>B15 2TT</Postal-Code>
      <Country>United Kingdom</Country>
    </Address>
  </Contributor>

  <Contributor iid="contrib2">
    <Person><First>Jon</First><Middle>L</Middle><Last>Hobman</Last></Person>
  </Contributor>

  <Contributor iid="contrib3">
    <Person><First>Charles</First><Middle>W</Middle><Last>Penn</Last></Person>
  </Contributor>

  <Contributor iid="contrib4">
    <Person><First>Mala</First><Last>Patel</Last></Person>
  </Contributor>

  <Contributor iid="contrib5">
    <Person><First>Antony</First><Middle>C</Middle><Last>Jones</Last></Person>
  </Contributor>

  <Contributor iid="contrib6">
    <Person><First>Andrew</First><Middle>M</Middle><Last>Bailey</Last></Person>
  </Contributor>

  <Contributor iid="contrib7">
    <Person><First>Chrystala</First><Last>Constantinodou</Last></Person>
  </Contributor>

  <Contributor iid="contrib8">
    <Person><First>Al</First><Last>Ivens</Last></Person>
  </Contributor>

  <Contributor iid="contrib9">
    <Person><First>Mark</First><Middle>I</Middle><Last>Garvey</Last></Person>
  </Contributor>

  <Contributor iid="contrib10">
    <Person><First>Mark</First><Middle>A</Middle><Last>Webber</Last></Person>
  </Contributor>

  <Contributor iid="contrib11">
    <Person><First>Nick</First><Last>Coldham</Last></Person>
  </Contributor>

  <Contributor iid="contrib12">
    <Person><First>John</First><Last>Wain</Last></Person>
  </Contributor>

  <Contributor iid="contrib13">
    <Person><First>Martin</First><Middle>J</Middle><Last>Woodward</Last></Person>
  </Contributor>

  <Contributor iid="contrib14">
    <Person><First>Laura</First><Middle>J</Middle><Last>Piddock</Last></Person>
  </Contributor>

  <Database iid="GEO">
    <Name>Gene Expression Omnibus (GEO)</Name>
    <Public-ID>GEO</Public-ID>
    <Organization>NCBI NLM NIH</Organization>
    <Web-Link>http://www.ncbi.nlm.nih.gov/geo</Web-Link>
    <Email>geo@ncbi.nlm.nih.gov</Email>
  </Database>

  <Platform iid="GPL3051">
    <Status database="GEO">
      <Submission-Date>2005-11-07</Submission-Date>
      <Release-Date>2006-01-07</Release-Date>
      <Last-Update-Date>2011-04-26</Last-Update-Date>
    </Status>
    <Title>UBEC Array3</Title>
    <Accession database="GEO">GPL3051</Accession>
    <Technology>spotted oligonucleotide</Technology>
    <Distribution>non-commercial</Distribution>
    <Organism taxid="562">Escherichia coli</Organism>
    <Manufacturer>UBEC, School of Biosciences, University of Birmingham, Birmingham, UK</Manufacturer>
    <Manufacture-Protocol>
The 70-mer oligonucleotide array was constructed, containing 6112 oligonucleotides that sampled chromosomal genes identified in the genome sequences of E. coli strains K-12 MG1655, O157:H7 VT2 Sakai, and O157:H7 EDL933 and plasmid genes from the two genome-sequenced O157:H7 strains (the Operon Array Ready E. coli Oligonucleotide™ set 1.0, Qiagen- Operon, Hilden, Germany). 12 positive and 12 negative control oligonucleotides were also included. The oligonucleotides were resuspended in Corning Pronto! buffer and printed on to Corning UltraGAPS™ slides (Corning B.V Life Sciences, Schiphol-Rijk, Netherlands ) using a Biorobotics Microgrid TAS array printer. Amersham Lucidea  Universal Scorecard™ controls (GE Healthcare, Little Chalfont, UK) were printed in each subarray. Slides were desiccated under vacuum for 48 hours and then U.V. cross-linked with a dose of 600mJ using a Stratalinker (Stratagene limited, U.K.). Slides were stored under desiccating conditions in the dark until use
    </Manufacture-Protocol>
    <Contributor-Ref ref="contrib1" position="1" />
    <Contributor-Ref ref="contrib2" position="2" />
    <Contributor-Ref ref="contrib3" position="3" />
    <Contributor-Ref ref="contrib4" position="4" />
    <Contributor-Ref ref="contrib5" position="5" />
    <Contact-Ref ref="contrib1" />
    <Data-Table>
      <Column position="1">
        <Name>ID</Name>
      </Column>
      <Column position="2">
        <Name>Array Block</Name>
        <Description>Block (subarray) number</Description>
      </Column>
      <Column position="3">
        <Name>Array Col</Name>
        <Description>Column number (within subarray)</Description>
      </Column>
      <Column position="4">
        <Name>Array Row</Name>
        <Description>Row number (within subarray)</Description>
      </Column>
      <Column position="5">
        <Name>Operon Oligo_ID</Name>
        <Description>ID of Operon Array_Ready Oligo</Description>
      </Column>
      <Column position="6">
        <Name>PT_GI</Name>
        <Description>Protein GenBank Identifier  </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&amp;DB=protein&amp;cmd=search&amp;term=</Link-Prefix>
        <Link-Suffix>[GI]</Link-Suffix>
      </Column>
      <Column position="7">
        <Name>SPOT_ID</Name>
        <Description>identifier for control spots</Description>
      </Column>
      <Column position="8">
        <Name>Control ID</Name>
        <Description>Name of control spots</Description>
      </Column>
      <Column position="9">
        <Name>Plate</Name>
        <Description>Source plate number</Description>
      </Column>
      <Column position="10">
        <Name>Plate Row</Name>
        <Description>Row in source plate</Description>
      </Column>
      <Column position="11">
        <Name>Plate Column</Name>
        <Description>Column in source plate</Description>
      </Column>
      <Column position="12">
        <Name>SEQUENCE</Name>
        <Description>Operon Oligonucleotide Sequence</Description>
      </Column>
      <Column position="13">
        <Name>MG1655 K12 ORF Name</Name>
        <Description>E.coli K12 MG1655 ORF name</Description>
      </Column>
      <Column position="14">
        <Name>MG1655 K12 Gene Symbol</Name>
        <Description>E.coli K12 MG1655 gene name</Description>
      </Column>
      <Column position="15">
        <Name>MG1655 K12 Map</Name>
        <Description>E.coli K12 MG1655 chromosome gene coordinates</Description>
      </Column>
      <Column position="16">
        <Name>MG1655 K12 DBid</Name>
        <Description>E.coli K12 MG1655 database ID information</Description>
      </Column>
      <Column position="17">
        <Name>MG1655 K12 Product</Name>
        <Description>E.coli K12 MG1655 gene product description</Description>
      </Column>
      <Column position="18">
        <Name>O157 EDL933 ORF Name</Name>
        <Description>E.coli O157 EDL 933 ORF name</Description>
      </Column>
      <Column position="19">
        <Name>O157 EDL933 Gene Symbol</Name>
        <Description>E.coli O157 EDL 933 gene name</Description>
      </Column>
      <Column position="20">
        <Name>O157 EDL933 Map</Name>
        <Description>E.coli O157 EDL 933 chromosome gene coordinates</Description>
      </Column>
      <Column position="21">
        <Name>O157 EDL933 DBid</Name>
        <Description>E.coli O157 EDL 933 database ID information</Description>
      </Column>
      <Column position="22">
        <Name>O157 EDL933 Product</Name>
        <Description>E.coli O157 EDL 933 gene product description</Description>
      </Column>
      <Column position="23">
        <Name>O157 Sakai ORF Name</Name>
        <Description>E.coli O157 Sakai ORF name</Description>
      </Column>
      <Column position="24">
        <Name>O157 Sakai  Gene Symbol</Name>
        <Description>E.coli O157 Sakai gene name</Description>
      </Column>
      <Column position="25">
        <Name>O157 Sakai Map</Name>
        <Description>E.coli O157 Sakai chromosome gene coordinates</Description>
      </Column>
      <Column position="26">
        <Name>O157 Sakai DBid</Name>
        <Description>E.coli O157 Sakai database ID information</Description>
      </Column>
      <Column position="27">
        <Name>O157 Sakai Product</Name>
        <Description>E.coli O157 Sakai gene product description</Description>
      </Column>
      <Column position="28">
        <Name>pO157 ORF Name</Name>
        <Description>E.coli O157 Sakai pO157 ORF name</Description>
      </Column>
      <Column position="29">
        <Name>pO157     Gene Symbol</Name>
        <Description>E.coli O157 Sakai pO157 gene name</Description>
      </Column>
      <Column position="30">
        <Name>pO157 Map</Name>
        <Description>E.coli O157 Sakai pO157 chromosome gene coordinates</Description>
      </Column>
      <Column position="31">
        <Name>pO157 DBid</Name>
        <Description>E.coli O157 Sakai pO157 database ID information</Description>
      </Column>
      <Column position="32">
        <Name>pO157 Product</Name>
        <Description>E.coli O157 Sakai pO157 gene product description</Description>
      </Column>
    <External-Data rows="14400">
GPL3051-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Platform>

  <Sample iid="GSM376029">
    <Status database="GEO">
      <Submission-Date>2009-03-02</Submission-Date>
      <Release-Date>2009-08-20</Release-Date>
      <Last-Update-Date>2009-08-19</Last-Update-Date>
    </Status>
    <Title>Triclosan exposure 1</Title>
    <Accession database="GEO">GSM376029</Accession>
    <Type>RNA</Type>
    <Channel-Count>2</Channel-Count>
    <Channel position="1">
      <Source>E. coli K12 MG1655, MOPS minimal media + 0.12 mg/L triclosan</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="strain">
K-12 MG1655
      </Characteristics>
      <Characteristics tag="media">
MOPS minimal medium + 0.12 mg/L triclosan
      </Characteristics>
      <Treatment-Protocol>
Upon the culture reaching mid-logarithmic growth phase (OD600 ~ 0.7 +/- 0.02), 0.12 mg/L triclosan was added and the culture incubated for an additional 30 min.
      </Treatment-Protocol>
      <Growth-Protocol>
Grown to mid-logarithmic phase (OD600 ~ 0.7 +/- 0.02) at 37 C, then incubated for an additional 30 min in the presence of 0.12 mg/L triclosan at 37 C.
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA isolation was performed using the Qiagen RNAprotectTM, RNeasy Mini Kit and RNase-free DNase sets according to the manufacturers’ instructions (Qiagen Ltd, Surrey, UK). The total RNA isolated from the cultures was quantified using an Agilent Bioanalyser 2100 RNA NanoLabchip, where, the quality of the RNA was indicated from the ratio of absorbance of 23S to 16S ribosomal RNA which was between 1.6 and 2.
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
20 µg total RNA was converted to Cy5-labelled cDNA using the CyScribe Post-Labelling Kit (Amersham Biosciences/GE Healthcare) according to manufacturer's instructions. Amino-allyl-labelled nucleotides were incorporated into the cDNA by reverse transcription of the total RNA, followed by a direct chemical coupling of Cy3 and Cy5 NHS-dye esters to the amino-allyl-labelled cDNAs.
      </Label-Protocol>
    </Channel>
    <Channel position="2">
      <Source>E. coli K12 MG1655, MOPS minimal media</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="strain">
K-12 MG1655
      </Characteristics>
      <Characteristics tag="media">
MOPS minimal medium
      </Characteristics>
      <Treatment-Protocol>
No treatment
      </Treatment-Protocol>
      <Growth-Protocol>
Grown to mid-logarithmic phase (OD600 ~ 0.7 +/- 0.02) at 37 C, then incubated for an additional 30 min at 37 C.
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA isolation was performed using the Qiagen RNAprotectTM, RNeasy Mini Kit and RNase-free DNase sets according to the manufacturers’ instructions (Qiagen Ltd, Surrey, UK). The total RNA isolated from the cultures was quantified using an Agilent Bioanalyser 2100 RNA NanoLabchip, where, the quality of the RNA was indicated from the ratio of absorbance of 23S to 16S ribosomal RNA which was between 1.6 and 2.
      </Extract-Protocol>
      <Label>Cy5</Label>
      <Label-Protocol>
20 µg total RNA was converted to Cy5-labelled cDNA using the CyScribe Post-Labelling Kit (Amersham Biosciences/GE Healthcare) according to manufacturer's instructions. Amino-allyl-labelled nucleotides were incorporated into the cDNA by reverse transcription of the total RNA, followed by a direct chemical coupling of Cy3 and Cy5 NHS-dye esters to the amino-allyl-labelled cDNAs.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Prehybridization of the array slides was performed for 4 h in filtered prehybridization solution [25 % formamide, 5x SSC, 10 mg l–1 BSA (fraction V), 0·1 % SDS] at 42 °C. Slides were briefly washed in ethanol and dried by centrifugation at 1000 g for 5 min. Hybridization of the probe was performed using hybridization solution (25 % formamide, 5x SSC, 0·1 % SDS, 0·1 µg poly(A) ml–1, 1x Denhardt's solution and 80 pmol Cy3 and Cy5 combined probe). The hybridization solution containing the Cy-Dye-labelled cDNA was heated to 95 °C for 3 min, Lifter slips (Erie Scientific) were placed on the array slides and the hybridization solution was applied between the Lifter slip and the array slide. The slides were incubated overnight at 42 °C in the dark in a Corning hybridization chamber (Corning Scientific). After hybridization, slides were washed in wash buffer I (2x SSC/0·1 % SDS) for 2 min at 42 °C, in wash buffer II (0·2x SSC) for 2 min at room temperature and then twice in wash buffer III (0·05x SSC) for 2 min at room temperature. All washes were done with vigorous shaking of the microarray slides. The slides were dried by centrifugation at 1000 g for 5 min.
    </Hybridization-Protocol>
    <Scan-Protocol>
Slides were analysed using an Axon Genepix 4000B microarray scanner, and Genepix 5.1 software (Axon Scientific).
    </Scan-Protocol>
    <Description>
An investigation in the transcriptomic effects upon exposure of Escherichia coli K12 MG1655 to the MIC (0.12 mg/L) of the biocide, triclosan.
    </Description>
    <Data-Processing>
Data were normalised by background subtraction using Kooperberg, then normalization using printtip loess (within arrays). Both functions were performed using the limma package (Smyth, G. K. (2005). Limma: linear models for microarray data. In: Bioinformatics and Computational Biology Solutions using R and Bioconductor, R. Gentleman, V. Carey, S. Dudoit, R. Irizarry, W. Huber (eds.), Springer, New York, pages 397-420).
    </Data-Processing>
    <Platform-Ref ref="GPL3051" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="GPR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM376nnn/GSM376029/GSM376029.gpr.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>CH1_MEAN</Name>
        <Description>Cy5 Mean Foreground</Description>
      </Column>
      <Column position="3">
        <Name>CH1_SD</Name>
        <Description>Cy5 Foreground SD</Description>
      </Column>
      <Column position="4">
        <Name>CH1_BKD_MEAN</Name>
        <Description>Cy5 Mean Backgound</Description>
      </Column>
      <Column position="5">
        <Name>CH1_BKD_SD</Name>
        <Description>Cy5 Background SD</Description>
      </Column>
      <Column position="6">
        <Name>CH2_MEAN</Name>
        <Description>Cy3 Mean Foreground</Description>
      </Column>
      <Column position="7">
        <Name>CH2_SD</Name>
        <Description>Cy3 Foreground SD</Description>
      </Column>
      <Column position="8">
        <Name>CH2_BKD_MEAN</Name>
        <Description>Cy3 Mean Backgound</Description>
      </Column>
      <Column position="9">
        <Name>CH2_BKD_SD</Name>
        <Description>Cy3 Background SD</Description>
      </Column>
      <Column position="10">
        <Name>VALUE</Name>
        <Description>log2 ratio of [(Cy3 Foreground - Background) / (Cy5 Foreground -Background)] representing test/control</Description>
      </Column>
      <Column position="11">
        <Name>PRE_VALUE</Name>
        <Description>(Cy5 Foreground - Background) / (Cy3 Foreground -Background)</Description>
      </Column>
      <Column position="12">
        <Name>INV_VALUE</Name>
        <Description>log ratio (log2 of PRE_VALUE)</Description>
      </Column>
    <External-Data rows="14400">
GSM376029-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM376033">
    <Status database="GEO">
      <Submission-Date>2009-03-02</Submission-Date>
      <Release-Date>2009-08-20</Release-Date>
      <Last-Update-Date>2009-08-19</Last-Update-Date>
    </Status>
    <Title>Triclosan exposure 2</Title>
    <Accession database="GEO">GSM376033</Accession>
    <Type>RNA</Type>
    <Channel-Count>2</Channel-Count>
    <Channel position="1">
      <Source>E. coli K12 MG1655, MOPS minimal media + 0.12 mg/L triclosan</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="strain">
K-12 MG1655
      </Characteristics>
      <Characteristics tag="media">
MOPS minimal medium + 0.12 mg/L triclosan
      </Characteristics>
      <Treatment-Protocol>
Upon the culture reaching mid-logarithmic growth phase (OD600 ~ 0.7 +/- 0.02), 0.12 mg/L triclosan was added and the culture incubated for an additional 30 min.
      </Treatment-Protocol>
      <Growth-Protocol>
Grown to mid-logarithmic phase (OD600 ~ 0.7 +/- 0.02) at 37 C, then incubated for an additional 30 min in the presence of 0.12 mg/L triclosan at 37 C.
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA isolation was performed using the Qiagen RNAprotectTM, RNeasy Mini Kit and RNase-free DNase sets according to the manufacturers’ instructions (Qiagen Ltd, Surrey, UK). The total RNA isolated from the cultures was quantified using an Agilent Bioanalyser 2100 RNA NanoLabchip, where, the quality of the RNA was indicated from the ratio of absorbance of 23S to 16S ribosomal RNA which was between 1.6 and 2.
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
20 µg total RNA was converted to Cy5-labelled cDNA using the CyScribe Post-Labelling Kit (Amersham Biosciences/GE Healthcare) according to manufacturer's instructions. Amino-allyl-labelled nucleotides were incorporated into the cDNA by reverse transcription of the total RNA, followed by a direct chemical coupling of Cy3 and Cy5 NHS-dye esters to the amino-allyl-labelled cDNAs.
      </Label-Protocol>
    </Channel>
    <Channel position="2">
      <Source>E. coli K12 MG1655, MOPS minimal media</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="strain">
K-12 MG1655
      </Characteristics>
      <Characteristics tag="media">
MOPS minimal medium
      </Characteristics>
      <Treatment-Protocol>
No treatment
      </Treatment-Protocol>
      <Growth-Protocol>
Grown to mid-logarithmic phase (OD600 ~ 0.7 +/- 0.02) at 37 C, then incubated for an additional 30 min at 37 C.
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA isolation was performed using the Qiagen RNAprotectTM, RNeasy Mini Kit and RNase-free DNase sets according to the manufacturers’ instructions (Qiagen Ltd, Surrey, UK). The total RNA isolated from the cultures was quantified using an Agilent Bioanalyser 2100 RNA NanoLabchip, where, the quality of the RNA was indicated from the ratio of absorbance of 23S to 16S ribosomal RNA which was between 1.6 and 2.
      </Extract-Protocol>
      <Label>Cy5</Label>
      <Label-Protocol>
20 µg total RNA was converted to Cy5-labelled cDNA using the CyScribe Post-Labelling Kit (Amersham Biosciences/GE Healthcare) according to manufacturer's instructions. Amino-allyl-labelled nucleotides were incorporated into the cDNA by reverse transcription of the total RNA, followed by a direct chemical coupling of Cy3 and Cy5 NHS-dye esters to the amino-allyl-labelled cDNAs.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
l 	Prehybridization of the array slides was performed for 4 h in filtered prehybridization solution [25 % formamide, 5x SSC, 10 mg l–1 BSA (fraction V), 0·1 % SDS] at 42 °C. Slides were briefly washed in ethanol and dried by centrifugation at 1000 g for 5 min. Hybridization of the probe was performed using hybridization solution (25 % formamide, 5x SSC, 0·1 % SDS, 0·1 µg poly(A) ml–1, 1x Denhardt's solution and 80 pmol Cy3 and Cy5 combined probe). The hybridization solution containing the Cy-Dye-labelled cDNA was heated to 95 °C for 3 min, Lifter slips (Erie Scientific) were placed on the array slides and the hybridization solution was applied between the Lifter slip and the array slide. The slides were incubated overnight at 42 °C in the dark in a Corning hybridization chamber (Corning Scientific). After hybridization, slides were washed in wash buffer I (2x SSC/0·1 % SDS) for 2 min at 42 °C, in wash buffer II (0·2x SSC) for 2 min at room temperature and then twice in wash buffer III (0·05x SSC) for 2 min at room temperature. All washes were done with vigorous shaking of the microarray slides. The slides were dried by centrifugation at 1000 g for 5 min.
    </Hybridization-Protocol>
    <Scan-Protocol>
Slides were analysed using an Axon Genepix 4000B microarray scanner, and Genepix 5.1 software (Axon Scientific).
    </Scan-Protocol>
    <Description>
An investigation in the transcriptomic effects upon exposure of Escherichia coli K12 MG1655 to the MIC (0.12 mg/L) of the biocide, triclosan.
    </Description>
    <Data-Processing>
Data were normalised by background subtraction using Kooperberg, then normalization using printtip loess (within arrays). Both functions were performed using the limma package (Smyth, G. K. (2005). Limma: linear models for microarray data. In: Bioinformatics and Computational Biology Solutions using R and Bioconductor, R. Gentleman, V. Carey, S. Dudoit, R. Irizarry, W. Huber (eds.), Springer, New York, pages 397-420).
    </Data-Processing>
    <Platform-Ref ref="GPL3051" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="GPR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM376nnn/GSM376033/GSM376033.gpr.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>CH1_MEAN</Name>
        <Description>Cy5 Mean Foreground</Description>
      </Column>
      <Column position="3">
        <Name>CH1_SD</Name>
        <Description>Cy5 Foreground SD</Description>
      </Column>
      <Column position="4">
        <Name>CH1_BKD_MEAN</Name>
        <Description>Cy5 Mean Backgound</Description>
      </Column>
      <Column position="5">
        <Name>CH1_BKD_SD</Name>
        <Description>Cy5 Background SD</Description>
      </Column>
      <Column position="6">
        <Name>CH2_MEAN</Name>
        <Description>Cy3 Mean Foreground</Description>
      </Column>
      <Column position="7">
        <Name>CH2_SD</Name>
        <Description>Cy3 Foreground SD</Description>
      </Column>
      <Column position="8">
        <Name>CH2_BKD_MEAN</Name>
        <Description>Cy3 Mean Backgound</Description>
      </Column>
      <Column position="9">
        <Name>CH2_BKD_SD</Name>
        <Description>Cy3 Background SD</Description>
      </Column>
      <Column position="10">
        <Name>VALUE</Name>
        <Description>log2 ratio of [(Cy3 Foreground - Background) / (Cy5 Foreground -Background)] representing test/control</Description>
      </Column>
      <Column position="11">
        <Name>PRE_VALUE</Name>
        <Description>(Cy5 Foreground - Background) / (Cy3 Foreground -Background)</Description>
      </Column>
      <Column position="12">
        <Name>INV_VALUE</Name>
        <Description>log ratio (log2 of PRE_VALUE)</Description>
      </Column>
    <External-Data rows="14400">
GSM376033-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM376035">
    <Status database="GEO">
      <Submission-Date>2009-03-02</Submission-Date>
      <Release-Date>2009-08-20</Release-Date>
      <Last-Update-Date>2009-08-19</Last-Update-Date>
    </Status>
    <Title>Triclosan exposure 3</Title>
    <Accession database="GEO">GSM376035</Accession>
    <Type>RNA</Type>
    <Channel-Count>2</Channel-Count>
    <Channel position="1">
      <Source>E. coli K12 MG1655, MOPS minimal media + 0.12 mg/L triclosan</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="strain">
K-12 MG1655
      </Characteristics>
      <Characteristics tag="media">
MOPS minimal medium + 0.12 mg/L triclosan
      </Characteristics>
      <Treatment-Protocol>
Upon the culture reaching mid-logarithmic growth phase (OD600 ~ 0.7 +/- 0.02), 0.12 mg/L triclosan was added and the culture incubated for an additional 30 min.
      </Treatment-Protocol>
      <Growth-Protocol>
Grown to mid-logarithmic phase (OD600 ~ 0.7 +/- 0.02) at 37 C, then incubated for an additional 30 min in the presence of 0.12 mg/L triclosan at 37 C.
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA isolation was performed using the Qiagen RNAprotectTM, RNeasy Mini Kit and RNase-free DNase sets according to the manufacturers’ instructions (Qiagen Ltd, Surrey, UK). The total RNA isolated from the cultures was quantified using an Agilent Bioanalyser 2100 RNA NanoLabchip, where, the quality of the RNA was indicated from the ratio of absorbance of 23S to 16S ribosomal RNA which was between 1.6 and 2.
      </Extract-Protocol>
      <Label>Cy5</Label>
      <Label-Protocol>
20 µg total RNA was converted to Cy5-labelled cDNA using the CyScribe Post-Labelling Kit (Amersham Biosciences/GE Healthcare) according to manufacturer's instructions. Amino-allyl-labelled nucleotides were incorporated into the cDNA by reverse transcription of the total RNA, followed by a direct chemical coupling of Cy3 and Cy5 NHS-dye esters to the amino-allyl-labelled cDNAs.
      </Label-Protocol>
    </Channel>
    <Channel position="2">
      <Source>E. coli K12 MG1655, MOPS minimal media</Source>
      <Organism taxid="562">Escherichia coli</Organism>
      <Characteristics tag="strain">
K-12 MG1655
      </Characteristics>
      <Characteristics tag="media">
MOPS minimal medium
      </Characteristics>
      <Treatment-Protocol>
No treatment
      </Treatment-Protocol>
      <Growth-Protocol>
Grown to mid-logarithmic phase (OD600 ~ 0.7 +/- 0.02) at 37 C, then incubated for an additional 30 min at 37 C.
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNA isolation was performed using the Qiagen RNAprotectTM, RNeasy Mini Kit and RNase-free DNase sets according to the manufacturers’ instructions (Qiagen Ltd, Surrey, UK). The total RNA isolated from the cultures was quantified using an Agilent Bioanalyser 2100 RNA NanoLabchip, where, the quality of the RNA was indicated from the ratio of absorbance of 23S to 16S ribosomal RNA which was between 1.6 and 2.
      </Extract-Protocol>
      <Label>Cy3</Label>
      <Label-Protocol>
20 µg total RNA was converted to Cy5-labelled cDNA using the CyScribe Post-Labelling Kit (Amersham Biosciences/GE Healthcare) according to manufacturer's instructions. Amino-allyl-labelled nucleotides were incorporated into the cDNA by reverse transcription of the total RNA, followed by a direct chemical coupling of Cy3 and Cy5 NHS-dye esters to the amino-allyl-labelled cDNAs.
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
Prehybridization of the array slides was performed for 4 h in filtered prehybridization solution [25 % formamide, 5x SSC, 10 mg l–1 BSA (fraction V), 0·1 % SDS] at 42 °C. Slides were briefly washed in ethanol and dried by centrifugation at 1000 g for 5 min. Hybridization of the probe was performed using hybridization solution (25 % formamide, 5x SSC, 0·1 % SDS, 0·1 µg poly(A) ml–1, 1x Denhardt's solution and 80 pmol Cy3 and Cy5 combined probe). The hybridization solution containing the Cy-Dye-labelled cDNA was heated to 95 °C for 3 min, Lifter slips (Erie Scientific) were placed on the array slides and the hybridization solution was applied between the Lifter slip and the array slide. The slides were incubated overnight at 42 °C in the dark in a Corning hybridization chamber (Corning Scientific). After hybridization, slides were washed in wash buffer I (2x SSC/0·1 % SDS) for 2 min at 42 °C, in wash buffer II (0·2x SSC) for 2 min at room temperature and then twice in wash buffer III (0·05x SSC) for 2 min at room temperature. All washes were done with vigorous shaking of the microarray slides. The slides were dried by centrifugation at 1000 g for 5 min.
    </Hybridization-Protocol>
    <Scan-Protocol>
Slides were analysed using an Axon Genepix 4000B microarray scanner, and Genepix 5.1 software (Axon Scientific).
    </Scan-Protocol>
    <Description>
An investigation in the transcriptomic effects upon exposure of Escherichia coli K12 MG1655 to the MIC (0.12 mg/L) of the biocide, triclosan.
    </Description>
    <Data-Processing>
Data were normalised by background subtraction using Kooperberg, then normalization using printtip loess (within arrays). Both functions were performed using the limma package (Smyth, G. K. (2005). Limma: linear models for microarray data. In: Bioinformatics and Computational Biology Solutions using R and Bioconductor, R. Gentleman, V. Carey, S. Dudoit, R. Irizarry, W. Huber (eds.), Springer, New York, pages 397-420).
    </Data-Processing>
    <Platform-Ref ref="GPL3051" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="GPR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM376nnn/GSM376035/GSM376035.gpr.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>CH1_MEAN</Name>
        <Description>Cy5 Mean Foreground</Description>
      </Column>
      <Column position="3">
        <Name>CH1_SD</Name>
        <Description>Cy5 Foreground SD</Description>
      </Column>
      <Column position="4">
        <Name>CH1_BKD_MEAN</Name>
        <Description>Cy5 Mean Backgound</Description>
      </Column>
      <Column position="5">
        <Name>CH1_BKD_SD</Name>
        <Description>Cy5 Background SD</Description>
      </Column>
      <Column position="6">
        <Name>CH2_MEAN</Name>
        <Description>Cy3 Mean Foreground</Description>
      </Column>
      <Column position="7">
        <Name>CH2_SD</Name>
        <Description>Cy3 Foreground SD</Description>
      </Column>
      <Column position="8">
        <Name>CH2_BKD_MEAN</Name>
        <Description>Cy3 Mean Backgound</Description>
      </Column>
      <Column position="9">
        <Name>CH2_BKD_SD</Name>
        <Description>Cy3 Background SD</Description>
      </Column>
      <Column position="10">
        <Name>VALUE</Name>
        <Description>log2 ratio of [(Cy5 Foreground - Background) / (Cy3 Foreground -Background)] representing test/control</Description>
      </Column>
      <Column position="11">
        <Name>PRE_VALUE</Name>
        <Description>(Cy5 Foreground - Background) / (Cy3 Foreground -Background)</Description>
      </Column>
    <External-Data rows="14400">
GSM376035-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Series iid="GSE15059">
    <Status database="GEO">
      <Submission-Date>2009-03-02</Submission-Date>
      <Release-Date>2009-08-20</Release-Date>
      <Last-Update-Date>2012-03-21</Last-Update-Date>
    </Status>
    <Title>The transcriptomic response of E. coli to triclosan exposure</Title>
    <Accession database="GEO">GSE15059</Accession>
    <Pubmed-ID>19759044</Pubmed-ID>
    <Summary>
The gene expression profile of E. coli K-12 MG1655 grown in minimal medium treated with 0.12 mg/L of the biocide triclosan has been analysed using whole genome oligonucleotide microarrays. &quot;Control&quot; RNA was isolated from three independently grown 50ml MOPS minimal media cultures of E. coli K-12 MG1655. “Test” RNA was isolated from three independently grown 50ml MOPS minimal cultures of E. coli K-12 MG1655, to which was added 0.12 mg/L of triclosan after reaching mid-logarithmic growth phase (OD600 ~ 0.7 +/- 0.02).
Keywords: dose response
    </Summary>
    <Overall-Design>
Cy5-labelled cDNA probes were synthesised from three independent biological extractions of RNA from E. coli MG1655 unexposed to triclosan. Cy3-labelled cDNA probes were synthesised from three independent biological extractions of RNA from E. coli MG1655 exposed to 0.12 mg/L of triclosan. A dye-swap control was also included, whereupon the control cDNA probes were labelled with Cy3 and the test cDNA probes labelled with Cy5. Probes were mixed to allow comparison of the control and test expression profiles and hybridised onto an E. coli spotted oligonucleotide array.
    </Overall-Design>
    <Type>Expression profiling by array</Type>
    <Contributor-Ref ref="contrib6" position="1" />
    <Contributor-Ref ref="contrib7" position="2" />
    <Contributor-Ref ref="contrib8" position="3" />
    <Contributor-Ref ref="contrib9" position="4" />
    <Contributor-Ref ref="contrib10" position="5" />
    <Contributor-Ref ref="contrib11" position="6" />
    <Contributor-Ref ref="contrib2" position="7" />
    <Contributor-Ref ref="contrib12" position="8" />
    <Contributor-Ref ref="contrib13" position="9" />
    <Contributor-Ref ref="contrib14" position="10" />
    <Contact-Ref ref="contrib1" />
    <Sample-Ref ref="GSM376029" />
    <Sample-Ref ref="GSM376033" />
    <Sample-Ref ref="GSM376035" />
    <Supplementary-Data type="TAR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/series/GSE15059/GSE15059_RAW.tar
    </Supplementary-Data>
    <Relation type="BioProject" target="http://www.ncbi.nlm.nih.gov/bioproject/114827" />
  </Series>

</MINiML>
